The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Jeevan Scientific Technology Ltd

Jeevan Scientific Technology Ltd

BSE 538837 · NSE JSTL · ISIN INE237B01018 · Group X · Active

Healthcare › Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology

₹73.15

-1.34%

BSE close, 28 August 2026

Market cap

₹146.89 cr

2.0 cr shares · Micro cap

Free float

₹89.43 cr

as published

P/E · P/B

25.6× · 2.86×

EPS ₹2.86 · BV ₹25.58

FY25-26 rev / PAT

53.93 / 1.65

₹ cr, as filed

Filings, window

14

3 selected · 21%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹32.85 52-WK HIGH ₹93.90 ₹73.15 66% of range
Against 52-week high-22.1%
Against 52-week low+122.7%
Day change-1.34%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹2.86
Price / earnings25.58×
Price / book2.86×
Book value — derived, price ÷ P/B₹25.58
Return on equity11.19%
Operating margin23.04%
Net margin11.14%

Consistency check

P/B ÷ P/E, which must equal ROE
11.18%
ROE as published
11.19%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 16.94 1.89 — 23.04% 11.14%
Mar-26 · Q 18.38 1.60 0.80 20.91% 8.68%
FY25-26 53.93 1.65 0.83 17.93% 3.06%

Quarter on quarter

Revenue, quarter on quarter
-7.8%
Net profit, quarter on quarter
+18.1%
Operating margin, quarter on quarter
+213 bps

Disclosure profile 14 filings in the window

0 median 17.0 p75 · 25 sector max 52 14 39th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Change in Management1
Results1
Selected sub-total3
Procedural
AGM / EGM4
General2
Annual Report1
Board Meeting1
Newspaper Publication1
Other Update1
Trading Window1
Procedural sub-total11
Total14

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

14 filings · 3 selected · busiest 2026-08-13

Filing rhythm · the twelve most recent

2026-08-132026-10-01

SelectedProcedural

Filings

14 in the window · 3 earlier on record

  1. 1 October 2026 ·

    General

    Closure Of The United States Food And Drug Administration (US FDA) Inspection Of JSTL And Issuance Of The Establishment Inspection Report (EIR), Received By The Company On 30.09.2026 .

    Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015

    Company Update / General View filing →

  2. 29 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015.

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 25 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Disclosure under Regulation 44(3) (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    AGM/EGM / AGM View filing →

  4. 25 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of 28th Annual General Meeting held on 25-09-2026

    AGM/EGM / AGM View filing →

  5. 4 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement -Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Company Update / Newspaper Publication View filing →

  6. 3 September 2026 ·

    AGM / EGM

    Intimation Of Book Closure And Cut-Off Date For The 28Th Annual General Meeting Of The Company

    Intimation of Book Closure and Cut- off date for the 28th Annual General Meeting of the Company

    AGM/EGM / AGM View filing →

  7. 3 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    28th Annual report

    Others / Reg. 34 (1) Annual Report View filing →

  8. 3 September 2026 ·

    AGM / EGM

    28Th Annual General Meeting Of The Company Is Schecduled To Be Held On 25.09.2026 At 10:00 A.M.

    28th Annual General meeting of the Company is scheduled to be held on 25.09.2026 at 10:00 a.m.

    AGM/EGM / AGM View filing →

  9. 13 August 2026 ·

    Other Update

    Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Statement on Deviation or Variation of funds under Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

    Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

  10. 13 August 2026 ·

    Change in Management

    Change in Management

    Announcement under Regulation 30 (LODR)- change in management

    Company Update / Change in Management View filing →

  11. 13 August 2026 ·

    Results

    Unaudited Financial Results (Standalone And Consoilidated) For The Quarter Ended 30.06.2026.

    Unaudited financial results (standalone and consolidated) for the quarter ended 30.06.2026.

    Result / Financial Results View filing →

  12. 13 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of The Board Meeting

    Outcome of the Board Meeting held on 13.08.2026

    Board Meeting / Outcome of Board Meeting View filing →

  13. 10 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 13.08.2026.

    Jeevan Scientific Technology Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Intimation of ....

    Board Meeting / Board Meeting View filing →

  14. 24 July 2026 ·

    General

    Information About The Successful Completion Of USFDA Inspection.

    Information about the Successful Completion of USFDA Inspection at JSTL under Regulation 30 of SEBI (LODR) Regulations, 2015.

    Company Update / General View filing →

RSS feed for Jeevan Scientific Technology Ltd · the 50 most recent filings